Concepedia
Statistics
Publications
36
Citations
4.1K
H-Index
29
Active since
1990
Affiliations
Harvard University(Current)
Massachusetts General Hospital
Pfizer (United States)
BioTransformations (United Kingdom)
Pfizer (Italy)
Aron D. Thall is an author at Harvard University specializing in life sciences, immunology, and immunotherapy.
Publications per year
1990–2021
The α(1,3)Fucosyltransferase Fuc-TVII Controls Leukocyte Trafficking through an Essential Role in L-, E-, and P-selectin Ligand Biosynthesis
Petr Malý, Aron D. Thall, Bronislawa Petryniak et al. · Cell · 1996 · 723 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +14
Oocyte Galα1,3Gal Epitopes Implicated in Sperm Adhesion to the Zona Pellucida Glycoprotein ZP3 Are Not Required for Fertilization in the Mouse
Aron D. Thall, Petr Malý, John B. Lowe · Journal of Biological Chemistry · 1995 · 402 citations · Full text
Life Sciences, Cell Biology, Genetics +16
The α(1,3)fucosyltransferases FucT-IV and FucT-VII Exert Collaborative Control over Selectin-Dependent Leukocyte Recruitment and Lymphocyte Homing
Jonathon W. Homeister, Aron D. Thall, B Petryniak et al. · Immunity · 2001 · 315 citations · Full text
Life Sciences, Immunology, Molecular Biology +16
Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer
Neil H. Segal, Aiwu Ruth He, Toshihiko Doi et al. · Clinical Cancer Research · 2018 · 279 citations
Pharmacy, Pharmacokinetics, Pharmacology +13
One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody
Uri Galili, F Anaraki, Aron D. Thall et al. · Blood · 1993 · 237 citations · Full text
Life Sciences, Cell Biology, Immunology +10
1–5 of 36